Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irfan Agha

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|April 22, 2006
BK virus and immunosuppressive agentsIrfan Agha, Daniel C Brennan
Transplantation Reviews (Orlando, Fla.)|January 17, 2017
Epstein-Barr virus and renal transplantationJade Le, Christine M Durand, Irfan Agha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 31, 2002
Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumorIrfan Agha, Robert Mahoney, Michael Beardslee, et al.
Transplantation|June 14, 2008
Campath induction for kidney transplantation: report of 297 casesJorge Ortiz, Juan Palma-Vargas, Francis Wright, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reductionDaniel C Brennan, Irfan Agha, Daniel L Bohl, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2020
High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injuryErik Stites, Dhiren Kumar, Oyedolamu Olaitan, et al.
Kidney International|June 7, 2025
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathyLaura Kooienga, Jeannette Lo, Eun Young Lee, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|April 22, 2006
BK virus and immunosuppressive agentsIrfan Agha, Daniel C Brennan
Transplantation Reviews (Orlando, Fla.)|January 17, 2017
Epstein-Barr virus and renal transplantationJade Le, Christine M Durand, Irfan Agha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 31, 2002
Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumorIrfan Agha, Robert Mahoney, Michael Beardslee, et al.
Transplantation|June 14, 2008
Campath induction for kidney transplantation: report of 297 casesJorge Ortiz, Juan Palma-Vargas, Francis Wright, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reductionDaniel C Brennan, Irfan Agha, Daniel L Bohl, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2020
High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injuryErik Stites, Dhiren Kumar, Oyedolamu Olaitan, et al.
Kidney International|June 7, 2025
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathyLaura Kooienga, Jeannette Lo, Eun Young Lee, et al.
Pageof 1